Soiken Holdings Inc
TSE:2385
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Soiken Holdings Inc
Operating Income
Soiken Holdings Inc
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Soiken Holdings Inc
TSE:2385
|
Operating Income
¥296.3m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
10%
|
|
|
Shiseido Co Ltd
TSE:4911
|
Operating Income
¥44.2B
|
CAGR 3-Years
21%
|
CAGR 5-Years
24%
|
CAGR 10-Years
2%
|
|
|
Rohto Pharmaceutical Co Ltd
TSE:4527
|
Operating Income
¥40.2B
|
CAGR 3-Years
5%
|
CAGR 5-Years
14%
|
CAGR 10-Years
10%
|
|
|
Kao Corp
TSE:4452
|
Operating Income
¥168.5B
|
CAGR 3-Years
14%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
0%
|
|
|
F
|
Fancl Corp
TSE:4921
|
Operating Income
¥11.3B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
12%
|
|
|
Kobayashi Pharmaceutical Co Ltd
TSE:4967
|
Operating Income
¥14.9B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-3%
|
|
Soiken Holdings Inc
Glance View
Soiken Holdings Inc. is engaged in the development of biomarkers and assessment systems. The company is headquartered in Toyonaka-Shi, Osaka-Fu and currently employs 104 full-time employees. The company went IPO on 2003-12-18. The firm operates in six business segments. The Biological Evaluation System segment is engaged in evaluation test of food and research support of medicine. The Healthcare Support segment is engaged in the provision of service about certain health guidance and healthcare insurance. The Cosmetics segment is engaged in manufacturing and sales of cosmetics. The Dietary Supplements segment is engaged in sales of unique dietary supplements. The Marketing segment is engaged in the marketing research of health supplement and sales of energy drink. The Functional Material Development segment is engaged in development and sales of functional materials, such as lactoferrin.
See Also
What is Soiken Holdings Inc's Operating Income?
Operating Income
296.3m
JPY
Based on the financial report for Dec 31, 2025, Soiken Holdings Inc's Operating Income amounts to 296.3m JPY.
What is Soiken Holdings Inc's Operating Income growth rate?
Operating Income CAGR 10Y
10%
The average annual Operating Income growth rates for Soiken Holdings Inc have been -33% over the past three years , -26% over the past five years , and 10% over the past ten years .
